Skip To Main Content
Inbar Finkel on Muck Rack

Inbar Finkel

As seen in: Wiley Online Library, Frontiers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Inbar

Contact Inbar, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Frontiers | BRAF and MEK inhibition beyond dabrafenib–trametinib in advanced thyroid cancer: a real-world case series

|
By Tzahi Yamin, Oded Cohen, Eyal Robenshtok, Elena Izkhakov, Orit Gutfeld, Yasmin Leshem, Anton Warshavsky, Nidal Muhanna, Inbar Finkel, Mor Miodovnik, Roman Meirovitz
| Frontiers
Introduction Thyroid cancer represents the most common endocrine malignancy, with papillary thyroid cancer (PTC) accounting for approximately 85% of cases (1, 2). While most PTCs have an excellent prognosis, a subset of patients develop aggressive, treatment-refractory disease. At the other end of the spectrum, anaplastic thyroid cancer (ATC) stands as one of the most lethal human malignancies, with a historical median survival of only 3–5 months (3, 4).
Open in Who Shared Issue with article?

Risk of Contralateral Central Compartment Recurrence Following Unilateral Therapeutic Neck Dissection for Papillary Thyroid Carcinoma

|
By Keren Kaminer, Tal Rozenblat, Itay Shavit, Inbar Finkel
| Wiley Online Library Verified
1 Introduction In patients with papillary thyroid carcinoma (PTC), central compartment lymph node (LN) metastases are common, ranging from occult microscopic foci detected in up to 30%–50% of patients on prophylactic dissection, to larger clinically apparent lymph node metastases (“clinical disease”) in up to 20% of patients [1, 2].
Open in Who Shared Issue with article?
See all 2 articles